Effectiveness of Narrative Exposure Therapy Among Refugee Children and Adolescents

October 15, 2018 updated by: Kirsi Peltonen, Tampere University

How to Help War-affected Children and Adolescents: the Role of Memory Functions in Therapeutic Intervention

This study aims to understand how war trauma affects children's and adolescents' memory functions and mental health, and whether Narrative Exposure Therapy is effective in enhancing optimal memory functions and alleviating mental health problems. The study analyzes the mental health and cognitive and emotional healing mechanisms of therapeutic intervention among war-affected children and adolescents.

Study Overview

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Helsinki, Finland
        • Centre for Torture Survivors
      • Tampere, Finland
        • Family Counselling Centre of the City of Tampere
      • Tampere, Finland
        • Psychiatric Clinic for Traumatized Children at Tampere University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

5 years to 13 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 9-17 years old
  • has spent some part of her/his life living in a country where organized violence was taking place, or at a refugee camp
  • suffers from significant stress symptoms thought be trauma-related

Exclusion Criteria:

  • acute psychosis
  • intellectual disability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Narrative Exposure Therapy
For the intervention group receiving Narrative Exposure Therapy treatment, the intervention will last for approximately three months and include 10-12 weekly sessions of 60-90 minutes. The course of the intervention will follow the NET manual (Schauer et al., 2011).
Active Comparator: Treatment as Usual
For the TAU control group, participants will receive the usual care for posttraumatic stress symptoms currently offered by each unit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Post-traumatic Stress as measured by Revised Impact of Event Scale
Time Frame: 9 months
9 months
Depression as measured by Depression Self-Rating Scale for Children
Time Frame: 9 months
9 months
Psychological Distress as measured by Strengths and Difficulties Questionnaire
Time Frame: 9 months
9 months
Resilience as measured by Child and Youth Resilience Measure
Time Frame: 9 months
9 months
Cognitive Performance as measured by Working Memory Test Battery for Children
Time Frame: 9 months
9 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Quality of Traumatic Memory as measured by Trauma Memory Quality Questionnaire
Time Frame: 9 months
9 months
Trauma Related Cognitions as measured by Children's Post Traumatic Cognitions Inventory
Time Frame: 9 months
9 months
General functioning of autobiographical memory as measured by reported life events
Time Frame: 9 months
9 months

Other Outcome Measures

Outcome Measure
Time Frame
Subjective distress during therapy measured by Subjective Units of Distress Scale
Time Frame: 9 months
9 months
Peritraumatic Dissociation measured by Peritraumatic Dissociative Experiences Questionnaire
Time Frame: once, at baseline
once, at baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2014

Primary Completion (Actual)

April 1, 2018

Study Completion (Actual)

April 1, 2018

Study Registration Dates

First Submitted

April 15, 2015

First Submitted That Met QC Criteria

April 22, 2015

First Posted (Estimate)

April 23, 2015

Study Record Updates

Last Update Posted (Actual)

October 17, 2018

Last Update Submitted That Met QC Criteria

October 15, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • 275804

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Treatment as Usual

Clinical Trials on Treatment as Usual

Subscribe